The Live Green Co. unveils two new functional ingredients from its precision fermentation division: GreenTAGs Human Milk Lipids for infant nutrition and GutRevyv Postbiotics for gut health.

Image courtesy of The Live Green Co.

Fermentation

The Live Green Co. Unveils Yeast-Derived Breast Milk Fat and Gut Health Postbiotic

The Live Green Co. (TLGC), a US food tech company headquartered in Boston since 2022, unveils two active functional ingredients developed with precision fermentation: GreenTAGs —  an analog of human breast milk fat known as OPO — and GutRevyv, a postbiotic for gut health. Human milk fat, mainly containing Triacylglycerols or OPO, plays a crucial role in infant development and health: It benefits nutrient absorption, supports neurodevelopment, boosts immunity, favors gut …

more

Yali Bio team

Yali Bio team © Yali Bio

Fermentation

Yali Bio Unveils Game-Changing Human Breast Milk Fat from Yeast, Set to Transform Nutritonal Value of Infant Formula

Yali Bio, a US biotech startup developing climate-smart ingredients using yeast in precision fermentation, announces a new game-changing development for infant nutrition: a bioidentical analog of human breast milk fat known as OPO. Yali Bio says that its yeast-derived OPO will optimize and enhance the nutritional value of infant formulas, improving infant health outcomes; according to the World Health Organization (WHO), 130 million newborn babies are fed infant formula at …

more

The Checkerspot team

The Checkerspot team © Checkerspot

Fermentation

Checkerspot Unveils “Breakthrough” for Baby Formula: Human Milk Fat Analog Made Using Microalgae Fermentation

California’s Checkerspot, a biotechnology firm that produces renewable oils by fermentation of microalgae, announces the development and large-scale production of fat analog that the company claims mimics the human milk fat known as OPO (Oleic-Palmitic-Oleic or sn-2 palmitate).  According to the company, this “breakthrough” achievement will revolutionize infant nutrition with essential lipids that contribute to better digestion and nutrient absorption and potentially offer long-term health benefits for infants. Making a human milk …

more

BIOMILQ Co-Founders

Leila Strickland & Michelle Egger ©BIOMILQ

Milk & Dairy

BIOMILQ Says Its Cell-Cultured Breast Milk Could Be Ready in 3-5 Years

BIOMILQ, a biotech startup producing human breast milk from cultured cells, reveals its technology is on pace to reach the market in the next three to five years. Aiming to disrupt the $52 billion infant formula industry, BIOMILQ is working to combine the nutrition of breast milk with the convenience and practicality of formula.  Based in North Carolina, BIOMILQ raised $21M in Series A funding in 2021 from backers that …

more